Iran, Islamic Republic of vs Zambia: Share of E. coli infections resistant to cephalosporins
Iran, Islamic Republic of
70.6%
in 2022
Zambia
76.5%
in 2022
Iran, Islamic Republic of rank
7th
Zambia rank
6th
Share of E. coli infections resistant to cephalosporins over time
- Iran, Islamic Republic of
- Zambia
How they compare
Zambia currently reports 76.5% against 70.6% in Iran, Islamic Republic of, a difference of 5.9%.
That makes Zambia's figure about 1.1 times Iran, Islamic Republic of's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Iran, Islamic Republic of ahead.
Iran, Islamic Republic of ranks 7th and Zambia ranks 6th of 46 countries.
Across the 2 decades both report, Iran, Islamic Republic of averaged higher in 1 and Zambia in 1.
Head to head by decade
| Decade | Iran, Islamic Republic of | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 80.2% | 57.5% | 22.7% | Iran, Islamic Republic of |
| 2020s | 70.0% | 88.4% | 18.4% | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Iran, Islamic Republic of or Zambia?
- Zambia, at 76.5% against 70.6% in Iran, Islamic Republic of as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Iran, Islamic Republic of and Zambia?
- 5.9%, with Zambia ahead.
- How many years of comparable data are there for Iran, Islamic Republic of and Zambia?
- 5 years are reported by both, from 2017 to 2022.
- How do Iran, Islamic Republic of and Zambia rank globally for share of e. coli infections resistant to cephalosporins?
- Iran, Islamic Republic of ranks 7th and Zambia ranks 6th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).